147 related articles for article (PubMed ID: 32692627)
1. Smartphone-Enhanced Training, QA, Monitoring, and Evaluation of a Platform for Secondary Prevention of Cervical Cancer: Opportunities and Challenges to Implementation in Tanzania.
Yeates K; Erwin E; Mtema Z; Magoti F; Nkumbugwa S; Yuma S; Hopman WM; Ferguson A; Oneko O; Macheku G; Mtei AF; Smith C; Andrews L; West N; Dalton M; Newcomb A; Ginsburg O
JCO Glob Oncol; 2020 Jul; 6():1114-1123. PubMed ID: 32692627
[TBL] [Abstract][Full Text] [Related]
2. Training, Supervision, and Competence Assessment of Cameroonian Health Care Providers Using HPV Self-Sampling, Triage by Visual Inspection, and Treatment by Thermal Ablation in a Single Visit.
Frund C; Kenfack B; Sormani J; Wisniak A; Fouogue JT; Tincho E; Metaxas T; Vassilakos P; Petignat P
Front Public Health; 2022; 10():875177. PubMed ID: 35419330
[TBL] [Abstract][Full Text] [Related]
3. Implementation of human papillomavirus video education for women participating in mass cervical cancer screening in Tanzania.
Cooper EC; Maher JA; Naaseh A; Crawford EW; Chinn JO; Runge AS; Lucas AN; Zezoff DC; Bera KR; Dinicu AI; White KM; Tewari SE; Hari A; Bernstein M; Chang J; Ziogas A; Pearre DC; Tewari KS
Am J Obstet Gynecol; 2021 Jan; 224(1):105.e1-105.e9. PubMed ID: 32682861
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings.
Asgary R; Beideck E; Naderi R
Prev Med; 2022 Jan; 154():106883. PubMed ID: 34785209
[TBL] [Abstract][Full Text] [Related]
5. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
[TBL] [Abstract][Full Text] [Related]
6. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
7. Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
Mwenda V; Bor JP; Nyangasi M; Njeru J; Olwande S; Njiri P; Arbyn M; Weyers S; Tummers P; Temmerman M
PLoS One; 2023; 18(5):e0286202. PubMed ID: 37228154
[TBL] [Abstract][Full Text] [Related]
8. Evaluating smartphone strategies for reliability, reproducibility, and quality of VIA for cervical cancer screening in the Shiselweni region of Eswatini: A cohort study.
Asgary R; Staderini N; Mthethwa-Hleta S; Lopez Saavedra PA; Garcia Abrego L; Rusch B; Marie Luce T; Rusike Pasipamire L; Ndlangamandla M; Beideck E; Kerschberger B
PLoS Med; 2020 Nov; 17(11):e1003378. PubMed ID: 33211691
[TBL] [Abstract][Full Text] [Related]
9. Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen-positive women: results from the ESTAMPA study.
Baena A; Mesher D; Salgado Y; Martínez S; Villalba GR; Amarilla ML; Salgado B; Flores B; Bellido-Fuentes Y; Álvarez-Larraondo M; Valls J; Lora O; Virreira-Prout G; Figueroa J; Turcios E; Soilán AM; Ortega M; Celis M; González M; Venegas G; Terán C; Ferrera A; Mendoza L; Kasamatsu E; Murillo R; Wiesner C; Broutet N; Luciani S; Herrero R; Almonte M;
Int J Cancer; 2023 Apr; 152(8):1581-1592. PubMed ID: 36451311
[TBL] [Abstract][Full Text] [Related]
10. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
11. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
12. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
13. Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.
Henke A; Kluge U; Borde T; Mchome B; Serventi F; Henke O
Glob Health Action; 2021 Jan; 14(1):1852780. PubMed ID: 33371824
[No Abstract] [Full Text] [Related]
14. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV.
Kahesa C; Thomsen LT; Linde DS; Mchome B; Katanga J; Swai P; Manongi R; Kjaerem M; Iftner T; Waldstrøm M; Mwaiselage J; Rasch V; Kjaer SK
Int J Cancer; 2023 Feb; 152(4):686-696. PubMed ID: 36093587
[TBL] [Abstract][Full Text] [Related]
15. Performance of HPV testing, Pap smear and VIA in women attending cervical cancer screening in Kilimanjaro region, Northern Tanzania: a cross-sectional study nested in a cohort.
Mremi A; Mchome B; Mlay J; Schledermann D; Blaakær J; Rasch V
BMJ Open; 2022 Oct; 12(10):e064321. PubMed ID: 36316070
[TBL] [Abstract][Full Text] [Related]
16. Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
Mremi A; Linde DS; Mchome B; Mlay J; Schledermann D; Blaakaer J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):802-810. PubMed ID: 33555038
[TBL] [Abstract][Full Text] [Related]
17. Deep learning-based image evaluation for cervical precancer screening with a smartphone targeting low resource settings - Engineering approach.
Hu L; Horning MP; Banik D; Ajenifuja OK; Adepiti CA; Yeates K; Mtema Z; Wilson B; Mehanian C
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():1944-1949. PubMed ID: 33018383
[TBL] [Abstract][Full Text] [Related]
18. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of implementing cervical cancer screening program using smartphone imaging as a training aid for nurses in rural India.
Sharma D; Rohilla L; Bagga R; Srinivasan R; Jindal HA; Sharma N; Kankaria A; Jamir L; Suri V; Singh RK; Duggal M
Public Health Nurs; 2018 Nov; 35(6):526-533. PubMed ID: 29806745
[TBL] [Abstract][Full Text] [Related]
20. Smartphone Use for Cervical Cancer Screening in Low-Resource Countries: A Pilot Study Conducted in Madagascar.
Catarino R; Vassilakos P; Scaringella S; Undurraga-Malinverno M; Meyer-Hamme U; Ricard-Gauthier D; Matute JC; Petignat P
PLoS One; 2015; 10(7):e0134309. PubMed ID: 26222772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]